lemborexant 5 MG Oral Tablet

RxCUI: 2272408
RxNorm name: lemborexant 5 MG Oral Tablet
Display name: lemborexant 5 MG Oral Tablet
Full name: lemborexant 5 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
DAYVIGO	LEMBOREXANT	Eisai Inc.	7074cb65-77b3-45d2-8e8d-da8dc0f70bfd	2025-02-24	Warnings, Adverse reactions	Exact identifier rxcui: 2272408

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
7074cb65-77b3-45d2-8e8d-da8dc0f70bfd	lemborexant 5 MG Oral Tablet	PSN	39	These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019	20250224
7074cb65-77b3-45d2-8e8d-da8dc0f70bfd	lemborexant 5 MG Oral Tablet	SCD	39	These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019	20250224